Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis

Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis

Background: Recently, Chinese patent medicines (CPMs) have been widely used to treat children with influenza in China, with curative effects. Therefore, the efficacy and safety of such treatment require further evaluation. The present meta-analysis integrated data from several independent studies to...

Full description

Bibliographic Details
Main Authors:	Nai-fan Duan, Bin Liu, Xiao-na Li, Yi-bai Xiong, Yan Zhang, Chi Zhang, Li LI, Cheng Lu, Jueni Lyu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Pharmacology
Subjects:	influenza children Chinese patent medicine oseltamivir meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.682732/full

Similar Items

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
by: Renee W. Y. Chan, et al.
Published: (2022-02-01)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
by: Parvaiz A Koul, et al.
Published: (2024-01-01)

Evaluation of the Clinical Effectiveness of Oseltamivir for Influenza Treatment in Children
by: Jianru Qin, et al.
Published: (2022-04-01)

Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons
by: Seoung Geun Kim, et al.
Published: (2013-04-01)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
by: Aeron C. Hurt, et al.
Published: (2016-06-01)

Oseltamivir Treatment for Influenza During the Flu Season of 2018–2019: A Longitudinal Study
by: Xiao-Guang Li, et al.
Published: (2022-05-01)

Traditional Chinese Medicine Injections Combined With Oseltamivir for Influenza: Systematic Review and Network Meta-Analysis
by: Yingying Peng, et al.
Published: (2022-07-01)

Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients
by: Lee JS, et al.
Published: (2020-05-01)

Synthesis and Biological Evaluation of <i>NH</i><sub>2</sub>-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors
by: Yaping Hu, et al.
Published: (2019-06-01)

Impact of Oseltamivir Treatment on Influenza A and B Virus Dynamics in Human Volunteers
by: Kyla L. Hooker, et al.
Published: (2021-03-01)

Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies
by: Hsieh NH, et al.
Published: (2017-07-01)

Oseltamivir Is Effective against 1918 Influenza Virus Infection of Macaques but Vulnerable to Escape
by: Friederike Feldmann, et al.
Published: (2019-10-01)

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
by: Chiara Medaglia, et al.
Published: (2021-06-01)

Effectiveness of Oseltamivir Prophylaxis in Influenza Outbreaks in Residential Aged Care
by: Mithilesh Dronavalli, et al.
Published: (2020-04-01)

Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial
by: Vladimir Rafalsky, et al.
Published: (2016-10-01)

Comparative effectiveness of oseltamivir versus peramivir for hospitalized children (aged 0-5 years) with influenza infection
by: Ming Xu, et al.
Published: (2023-03-01)

Clinical efficacy and safety of baloxavir marboxil in the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials
by: Yu-Chi Kuo, et al.
Published: (2021-10-01)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
by: Esther H. Fietjé, et al.
Published: (2012-03-01)

Discovery of Novel Boron-Containing <em>N</em>-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant
by: Ruifang Jia, et al.
Published: (2022-09-01)

Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
by: Zhichao Xu, et al.
Published: (2022-06-01)

Oseltamivir for the treatment of influenza in children and adolescents
by: Alfredo Tagarro, et al.
Published: (2019-05-01)

A Model-based Assessment of Oseltamivir Prophylaxis Strategies to Prevent Influenza in Nursing Homes
by: Carline van den Dool, et al.
Published: (2009-10-01)

Rapid Emergence of Oseltamivir Resistance
by: Cheng Len Sy, et al.
Published: (2010-04-01)

Widespread Oseltamivir Resistance in Influenza A Viruses (H1N1), South Africa
by: Terry G. Besselaar, et al.
Published: (2008-11-01)

Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial
by: Karel Rauš, et al.
Published: (2015-12-01)

Rate of use and effectiveness of oseltamivir in the treatment of influenza illness in high‐risk populations: A systematic review and meta‐analysis
by: So‐Jung Shim, et al.
Published: (2021-03-01)

Assay to Detect Oseltamivir Resistance
by: Kamol Suwannakarn, et al.
Published: (2006-12-01)

Oseltamivir- and Amantadine-Resistant Influenza Virus A (H1N1)
by: Peter K.C. Cheng, et al.
Published: (2010-01-01)

Dispensação de Oseltamivir no Município de Passo Fundo - RS
by: Gilberto Santetti, et al.
Published: (2012-01-01)

Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan
by: Makoto Ujike, et al.
Published: (2010-06-01)

A multiplex real-time PCR assay for detection of oseltamivir-resistant strains of influenza virus
by: Nidzworski Dawid, et al.
Published: (2014-06-01)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea
by: Hwajung Yi, et al.
Published: (2010-12-01)

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
by: Jiwei Zhang, et al.
Published: (2023-12-01)

Three-day regimen of oseltamivir for post-exposure prophylaxis of influenza in hospital wards: a study protocol for a prospective, multi-center, single-arm trial
by: Nobuhisa Ishiguro, et al.
Published: (2021-08-01)

Risk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivir
by: Anna Gillman
Published: (2016-10-01)

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
by: Mariana Baz, et al.
Published: (2018-11-01)

Determination of Oseltamivir Quality by Colorimetric and Liquid Chromatographic Methods
by: Michael D. Green, et al.
Published: (2008-04-01)

Monitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009–2010
by: Makoto Ujike, et al.
Published: (2011-03-01)

Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial
by: Min Li, et al.
Published: (2020-11-01)

Assessment of influenza A (H1N1, H3N2) oseltamivir resistance during 2017-2019 in Iran
by: Amytis Gholami, et al.
Published: (2022-08-01)